| Disclosure of secondary findings in exome sequencing of 2480 Japanese cancer patients Y Horiuchi, H Matsubayashi, Y Kiyozumi, S Nishimura, S Higashigawa, ... Human Genetics 140, 321-331, 2021 | 20 | 2021 |
| Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patients K Yamaguchi, K Urakami, T Nagashima, Y Shimoda, S Ohnami, ... Biomedical Research 37 (4), 259-264, 2016 | 8 | 2016 |
| Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer: A STROBE-compliant observational study R Tanaka, J Sato, H Ishikawa, T Sato, M Shino, Y Ohde, T Sato, K Mori, ... Medicine 100 (44), e27565, 2021 | 6 | 2021 |
| JCGA: the Japanese version of the Cancer Genome Atlas and its contribution to the interpretation of gene alterations detected in clinical cancer genome sequencing M Serizawa, M Mizuguchi, K Urakami, T Nagashima, K Ohshima, ... Human Genome Variation 8 (1), 38, 2021 | 3 | 2021 |
| Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes S Ohnami, A Naruoka, M Isaka, M Mizuguchi, S Nakatani, F Kamada, ... Scientific Reports 12 (1), 17928, 2022 | 1 | 2022 |
| Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients Y Shimoda, T Nagashima, K Urakami, F Kamada, S Nakatani, ... Biomedical Research 43 (4), 115-126, 2022 | 1 | 2022 |
| Sharing genetic test results of germline pathogenic variants of hereditary cancer with relatives: A single-center cross-sectional study N Fukuzaki, Y Kiyozumi, S Higashigawa, Y Horiuchi, M Mizuguchi, ... Japanese journal of clinical oncology 51 (10), 1547-1553, 2021 | 1 | 2021 |
| Utilization of Japanese cancer genome database (JCGA) in the interpretation of results in cancer gene panel tests H Kenmotsu, M Serizawa, M Mizuguchi, N Mamesaya, H Shirasu, ... CANCER SCIENCE 113, 496-496, 2022 | | 2022 |
